Technology

March 30, 2010 – The FDA granted tentative approval for Teva Pharmaceutical’s abbreviated new drug application (ANDA) to market a generic version of the anti-coagulant, Argatroban injection, 100mg/mL.

Home March 30, 2010
Home
News

March 29, 2010 - Optical coherence tomography (OCT) not only has the potential to identify vulnerable plaques, but in countries like Japan, it is already a standard follow up to stenting procedures to determine if the stent has effectively widened the affected artery and the area is free of blood clots.

Home March 29, 2010
Home
News

March 29, 2010 – A lawsuit was settled between Medtronic and AGA Medical Corp. for the alleged infringement of patents concerning the use of stress to restrain self-expanding nitinol medical devices. Under the terms of the settlement AGA will pay an undisclosed amount to Medtronic and Medtronic will grant a nonexclusive license to AGA to use the patent.

Home March 29, 2010
Home
News

March 29, 2010 - Medical industry leaders gather this week to discuss steps manufacturers of CT and fluoroscopy systems can take to reduce unnecessary patient exposure to ionizing radiation.

Home March 29, 2010
Home
Technology

March 29, 2010 – A new multiparameter ambulatory monitoring solution that transmits electrocardiogram (ECG) and other clinical modalities via cellular network, enables real-time data analysis for more expedient triaging of critical patients. ScottCare Corp. just launched TeleSentry, the latest innovation to its CardioView Dx suite of cardiovascular diagnostic solutions.

Home March 29, 2010
Home
News

March 24, 2010 — Several genes are associated with heart disease, stroke, and high blood pressure, and can determine whether people may have predisposition to these conditions, according to genetics research.

Home March 26, 2010
Home
News

March 26, 2010 – The first implantations were announced yesterday for a single-chamber implantable cardioverter defibrillator. The system provides physicians with complete diagnostic information not only from the right ventricle, as in regular single-chamber ICDs, but also from the right atrium, including high-resolution online IEGMs.

Home March 26, 2010
Home
News

March 26, 2010 — The American College of Cardiology (ACC) and Heart Rhythm Society (HRS) recently announced a new collaboration to build and deliver innovative programs and resources for cardiology clinicians treating patients with atrial fibrillation (AF).

Home March 26, 2010
Home
Technology

March 26, 2010 – The FDA granted 510(k) market clearance for the AngioSculpt PTA Scoring Balloon Catheter for dilatation of lesions in renal arteries.

Home March 26, 2010
Home
News

March 26, 2010 – Nearly 14 percent of Medicare beneficiaries admitted with a primary diagnosis of ST-elevated myocardial infarction (STEMI) undergo multivessel primary percutaneous coronary intervention (PCI), despite recommendations from the American College of Cardiology and the American Heart Association to intervene on only the culprit vessel.

Home March 26, 2010
Home
Feature

March 26, 2010 – When actor John Ritter died suddenly in 2003 from a tear in his thoracic aorta, the tragedy brought attention to a rare but deadly condition that takes the lives of an estimated 10,000 Americans each year.

Home March 26, 2010
Home
News

March 25, 2010 – The FDA this week granted permission for a conditional investigational device exemption (IDE) to evaluate the safety and efficacy of a transcatheter plug to seal the left atrial appendage (LAA). The appendage is frequently the source of stroke-causing clots in atrial fibrillation patients.

Home March 25, 2010
Home
News

March 25, 2010 – Recognizing that a single database cardiovascular information system(CVIS) can streamline workflow and improve staff efficiency in the cardiology department, several hospitals are replacing their legacy hemodynamic systems with a unified CVIS.

Home March 25, 2010
Home
News

March 25, 2010 – The Transradial University Web site was launched this week to help expand the use of transradial access as an alternative vascular access site. As transradial adoption expands in the U.S., two key limiting factors are training and experience.

Home March 25, 2010
Home
Feature | Dave Fornell

Final five-year results from the ENDEAVOR III trial, comparing the Endeavor Zotarolimus-Eluting Coronary Stent to the Cypher Sirolimus-Eluting Coronary Stent, showed Endeavor had lower long-term rates of adverse events, cardiovascular death and heart attacks. The results were released last week during the American College of Cardiology’s 59th Scientific Session.

Home March 24, 2010
Home
Subscribe Now